Fatal Salmonella pulmonary arteritis in a patient with Eisenmenger syndrome.

1. Brites C, Oliveira AS, Netto EM. Coinfection with HIV and human T lymphotropic virus type 1: what is the real impact of HIV disease? Clin Infect Dis 2004; 40:329–30 (in this issue). 2. Beilke MA, Theall K, O’Brien M, et al. Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2. Clin Infect Dis 2004; 39:256–63. 3. Hershow RC, Galai N, Fukuda K, et al. An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J Infect Dis 1996; 174:309–17. 4. Giacomo M, Franco EG, Claudio C, et al. Human T-cell leukemia virus type II infection among high risk groups and its influence on HIV-1 disease progression. Eur J Epidemiol 1995; 11:527–33. 5. Graham NH, Hoover DR, Park LP, et al. Survival in HIV-infected patients who have received zidovudine: comparison of combination therapy with sequential monotherapy and continued zidovudine monotherapy. Ann Int Med 1996; 124:1031–8. 6. Glesby MJ, Hoover DR. Survivor treatment selection bias in observational studies: examples from the AIDS literature. Ann Int Med 1996; 124:999–1005. 7. Brookmeyer R, Gail MH, Polk BF. The prevalent cohort study and the acquired immunodeficiency syndrome. Am J Epidemiol 1987; 126:14–24.